Prosecution Insights
Last updated: April 19, 2026

Integrated Dna Technologies Inc.

8 pending office actions

Portfolio Summary

8
Total Pending OAs
0
Final Rejections
8
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18418248 S. PYOGENES CAS9 MUTANT GENES AND POLYPEPTIDES ENCODED BY SAME NOAKES, SUZANNE MARIE 1656 Non-Final OA Jan 20, 2024
18535790 METHODS FOR MULTIPLEX PCR HORLICK, KENNETH R 1681 Non-Final OA Dec 11, 2023
18450149 UBIQUITIN VARIANT WITH HIGH AFFINITY FOR BINDING 53BP1 REDUCES THE AMOUNT OF AAV NEEDED TO ACHIEVE HIGH RATES OF HDR GRIZER, CASSANDRA SENN 1672 Non-Final OA Aug 15, 2023
18316454 USE OF UNIQUE MOLECULAR IDENTIFIERS FOR IMPROVED ACCURACY OF LONG READ SEQUENCING AND CHARACTERIZATION OF CRISPR EDITING GRAY, JESSICA 1682 Non-Final OA May 12, 2023
18176091 C-TERMINAL PEPTIDE EXTENSIONS WITH INCREASED ACTIVITY HUTSON, RICHARD G 1652 Non-Final OA Feb 28, 2023
18161654 RECOMBINATION-BASED DNA ASSEMBLY METHODS AND COMPOSITIONS LEE, JAE W 1656 Non-Final OA Jan 30, 2023
18054982 METHODS FOR LIGATION-COUPLED-PCR KOVACH, KARA NICOLE 1681 Non-Final OA Nov 14, 2022
17208286 DNA POLYMERASE MUTANTS HAVING ENHANCED TEMPLATE DISCRIMINATION ACTIVITY HUTSON, RICHARD G 1652 Non-Final OA Mar 22, 2021

Managing Integrated Dna Technologies Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month